| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 38.76B | 41.51B | 40.84B | 49.53B | 32.85B |
| Gross Profit | 9.02B | 10.90B | 11.77B | 16.26B | 10.58B |
| EBITDA | 17.99B | 15.41B | 17.27B | 21.73B | 16.38B |
| Net Income | 10.82B | 6.11B | 8.23B | 10.94B | 7.66B |
Balance Sheet | |||||
| Total Assets | 91.83B | 85.36B | 75.95B | 76.14B | 76.67B |
| Cash, Cash Equivalents and Short-Term Investments | 673.00M | 131.00M | 1.40B | 1.41B | 1.05B |
| Total Debt | 19.72B | 20.28B | 12.35B | 12.98B | 16.28B |
| Total Liabilities | 47.46B | 45.89B | 36.12B | 37.97B | 39.72B |
| Stockholders Equity | 44.37B | 39.47B | 39.83B | 38.17B | 36.95B |
Cash Flow | |||||
| Free Cash Flow | 8.43B | 8.00B | 7.44B | 14.29B | 9.99B |
| Operating Cash Flow | 15.11B | 13.39B | 12.35B | 19.39B | 14.48B |
| Investing Cash Flow | -6.69B | -14.10B | -4.86B | -4.99B | -3.70B |
| Financing Cash Flow | -7.88B | -37.00M | -7.54B | -14.23B | -10.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$133.75B | 8.98 | 25.98% | 5.23% | 8.06% | -10.64% | |
76 Outperform | C$7.42B | 30.68 | 7.90% | 3.76% | -1.59% | 0.09% | |
74 Outperform | C$17.73B | 11.60 | 10.14% | 6.33% | 36.36% | -19.92% | |
71 Outperform | C$14.96B | 11.74 | 15.52% | 2.95% | 15.61% | 12.15% | |
70 Outperform | C$8.57B | -15.31 | 15.77% | 2.99% | -11.41% | 40.81% | |
69 Neutral | C$24.00B | 89.45 | 8.69% | 4.79% | 8.97% | -21.15% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |